Globus Medical (GMED) Net Shares Issued and Repurchased (2019 - 2025)

Globus Medical (GMED) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Net Shares Issued and Repurchased rose 16.1% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2025 stood at $1.7 million (up 16.1% YoY), and the FY2024 full-year result was $2.8 million, up 47.02% from the prior year.
• Net Shares Issued and Repurchased fell to $1.7 million in Q1 2025 per GMED's latest filing, from $2.8 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.8 million in Q4 2024 and bottomed at $1.2 million in Q1 2023.
• Historically, Net Shares Issued and Repurchased has averaged $1.9 million across 5 years, with a median of $1.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased tumbled 30.67% in 2023, then soared 47.02% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.2 million in 2021, then grew by 26.43% to $2.7 million in 2022, then slumped by 30.67% to $1.9 million in 2023, then jumped by 47.02% to $2.8 million in 2024, then sank by 39.51% to $1.7 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.7 million, $2.8 million, and $1.5 million for Q1 2025, Q4 2024, and Q1 2024 respectively.